You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Drug-delivering aptamers target leukemia stem cells for one-two knockout punch
- 2. Deep cross entropy fusion for pulmonary nodule classification based on ultrasound Imagery
- 3. Preliminary investigation of gut microbiota and associated metabolic pathways in the pathogenesis of primary central nervous system lymphoma
- 4. Pembrolizumab versus bevacizumab plus modified FOLFOX6 in metastatic MSI-H/dMMR colorectal cancer: a multicenter retrospective study with CT evaluation
- 5. Tocilizumab improves the efficacy of anti-PD-1 in a patient with advanced gastroesophageal junction cancer: a case report
- 6. Longevity Medical Institute™ Integrates OncoSeek® to Launch One of Mexico's Most Advanced Cancer Screening Programs
- 7. In pancreatic cancer, a race against time
- 8. In pancreatic cancer, a race against time
- 9. Cancer-associated fibroblasts: multidimensional players in liver cancer
- 10. Rare case report: primary small-cell neuroendocrine carcinoma of the gallbladder
Last updated at 1:48 GMT
Hot News Makers
Health/Pharma Companies
-
130096.10
-
31393.91
-
15538.49
-
10512.40
-
9125.65
-
8310.48
-
6289.92
-
5099.82
-
4591.96
-
4583.39
Drugs, Treatments, Trials
-
11003.04
-
7825.90
-
7286.28
-
6218.28
-
5100.46
-
3339.63
-
3236.80
-
2812.42
-
2429.01
-
2261.35
Last updated at 1:10 GMT
